Pricing Disparities - The price of a certain drug in London is significantly lower at $130 compared to $1,300 in New York, indicating a stark pricing disparity in the pharmaceutical market [1][2] - The new pricing strategy will bring the cost down to approximately $150 for both markets, promoting a "favored nations" pricing model [1] Drug Categories and Negotiations - The discussion revolves around GLP (glucagon-like peptide) category drugs, including weight loss medications like Ozempic, which have not yet undergone price negotiations [2][3] - There is an expectation that prices for these drugs will decrease rapidly once negotiations commence, although no specific timeline for these negotiations has been provided [3]